Mounjaro (tirzepatide) is a once-weekly prescription injection that activates GIP and GLP-1 receptors. These receptors influence appetite, digestion, and food intake. By helping patients feel less hungry and satisfied with smaller portions, tirzepatide may support gradual weight reduction when combined with balanced nutrition, physical activity, and sustainable lifestyle changes.

Mounjaro and Zepbound contain the same active ingredient, tirzepatide, but they have different FDA-approved uses. Mounjaro is not FDA-approved specifically for weight loss; Zepbound is the tirzepatide brand approved for chronic weight management in eligible adults. Patients should receive the medication only after a medical evaluation confirms that tirzepatide is appropriate for their health needs.

At Cape Fear Physical Medicine and Rehab, we review each patient’s weight history, medications, medical concerns, previous weight-loss efforts, and goals before recommending tirzepatide treatment. Regular follow-up helps monitor appetite, weight changes, medication tolerance, and possible side effects.

Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors. These receptors are involved in regulating appetite and food intake. By influencing appetite-related areas of the brain, tirzepatide may help patients feel less hungry, become satisfied with smaller portions, and consume fewer calories.

Tirzepatide is administered as a once-weekly injection under the skin. Weight loss generally develops gradually when treatment is combined with reduced-calorie eating, increased physical activity, and sustainable lifestyle changes. Although Mounjaro contains tirzepatide, the FDA-approved tirzepatide brand specifically indicated for chronic weight management is Zepbound.

At Cape Fear Physical Medicine and Rehab, we evaluate each patient’s health history, medications, previous weight-loss efforts, and goals before recommending tirzepatide. Regular follow-up allows her to monitor appetite changes, weight-management progress, medication tolerance, and possible side effects while adjusting the treatment plan when medically appropriate.

Tirzepatide injections may offer several benefits when used as part of a medically supervised weight-management program. For chronic weight management, tirzepatide is FDA-approved under the brand name Zepbound; Mounjaro contains the same active ingredient but is marketed under a different approved indication.

Potential weight-loss benefits include:

• Reduced appetite: Tirzepatide may decrease hunger and help patients consume fewer calories.
• Longer-lasting fullness: Patients may feel satisfied for longer after eating.
• Improved portion control: Reduced hunger may make smaller, balanced portions easier to maintain.
• Meaningful weight reduction: Clinical studies have shown substantial weight loss in eligible adults when treatment is combined with reduced-calorie eating and increased physical activity.
• Long-term weight management: Continued treatment and healthy lifestyle habits may help patients maintain weight reduction.
• Once-weekly dosing: Tirzepatide is administered once weekly, which may make treatment more convenient.
• Greater fat-mass reduction: Weight reduction generally includes a greater loss of fat mass than lean mass.

At Cape Fear Physical Medicine and Rehab in Fayetteville, NC, Board-Certified Dr. Meisha K. Abbasinejad, MD, evaluates each patient’s health history, medications, weight-loss goals, and potential risk factors before recommending tirzepatide treatment. Regular follow-up helps her monitor appetite, weight changes, medication tolerance, and possible side effects.

Adults who may qualify for tirzepatide injections for weight loss are identified through a personalized medical evaluation. For FDA-approved chronic weight management, tirzepatide is marketed under the brand name Zepbound. Eligibility generally depends on body mass index, weight-related health concerns, medical history, current medications, and treatment goals.

Potential candidates may include:

• Adults with a BMI of 30 or higher: This falls within the obesity range.
• Adults with a BMI of 27 or higher: They may qualify when they also have a weight-related concern, such as high cholesterol, high blood pressure, cardiovascular disease, or obstructive sleep apnea.
• Individuals needing additional weight-management support: Candidates should be prepared to combine medication with reduced-calorie eating and increased physical activity.
• Patients without specific contraindications: Tirzepatide should not be used by individuals with a personal or family history of medullary thyroid carcinoma or MEN 2.
• Patients who are not pregnant: Weight-loss treatment is not recommended during pregnancy.
• Individuals able to receive ongoing monitoring: Medical history, digestive health, medications, side effects, and treatment response should be reviewed regularly.

At Cape Fear Physical Medicine and Rehab, Dr. Meisha K. Abbasinejad, MD, evaluates each patient individually to determine whether tirzepatide injections may be appropriate for their weight-management needs.

Choosing Board-Certified Obesity Medicine Physician Dr. Meisha K. Abbasinejad, MD, for medically supervised Mounjaro weight loss care provides patients with an individualized evaluation before treatment begins. She reviews weight history, previous weight loss efforts, current medications, medical conditions, eating habits, activity level, and personal goals to determine whether tirzepatide may be clinically appropriate. She also explains dosing, potential benefits, possible side effects, and the importance of combining medication with sustainable lifestyle changes.

Throughout treatment, Dr. Abbasinejad monitors appetite, weight changes, medication tolerance, and overall progress through regular follow-up visits. At Cape Fear Physical Medicine and Rehab in Fayetteville, NC, she provides personalized nutrition, physical activity, and behavioral guidance while adjusting the treatment plan when medically necessary. This ongoing supervision helps patients pursue realistic weight loss goals with care tailored to their individual health needs and response. Contact us today or schedule an appointment online to learn more and take the next step toward achieving your health and wellness goals. We are conveniently located at 1540 Purdue Dr, Ste. 200, in Fayetteville, NC 28303. We serve patients from Fayetteville NC, Woodfield NC, Hope Mills NC, Fort Bragg NC, Eastover NC, and surrounding areas.